In SSRI withdrawal, brain zaps go from overlooked symptom to center stage (2023)
Brain “zaps” – brief, electric-shock-like sensations in the head – are emerging as a widely reported and often debilitating withdrawal symptom when stopping or missing doses of antidepressants such as SSRIs and SNRIs. Commenters describe a spectrum of experiences: for some, these drugs are life-saving and manageable with careful tapering; for others, withdrawal (especially from drugs like sertraline, venlafaxine, and duloxetine) involves prolonged zaps, dizziness, and emotional instability that doctors initially downplayed or did not recognize. Alongside personal accounts, people debate the quality of psychiatric practice, the role of pharma, and the value of alternative or adjunct approaches like therapy, lifestyle changes, ketamine, and non-SSRI medications.
Overall range of experiences with SSRIs/SNRIs
- Many report SSRIs/SNRIs as life‑saving: reduced severe depression/anxiety, allowed normal functioning, “gave life back,” often with minimal ongoing side effects.
- Others describe profound negatives: emotional numbing, loss of motivation/creativity, cognitive fog, memory issues, sexual dysfunction, sleep problems, and feeling “like a zombie.”
- Responses are highly individual: same drug can be a “godsend” for one person and disastrous or ineffective for another.
What brain zaps feel like
- Commonly described as brief electric shocks or “degaussing” in the head; like hitting the funny bone, teeth-whitening zaps, or a YouTube video buffering in the brain.
- Often triggered or worsened by eye or head movement, or peripheral visual motion; some report a momentary loss of train of thought or “skipped second” of life.
- Typically occur during withdrawal or missed doses of SSRIs/SNRIs, but some report similar sensations with MDMA, other psych meds, long Covid, panic disorder, or even lifelong without drugs.
- Severity ranges from mildly annoying to debilitating, sometimes lasting weeks to months; a few fear long‑term or permanent changes.
Withdrawal and tapering
- Many accounts of severe withdrawal from sertraline, venlafaxine (Effexor), duloxetine (Cymbalta), paroxetine (Paxil), etc., even with planned tapers.
- Strategies include very slow dose reductions over many months, bead-counting from capsules, microgram scales, and cross‑tapering to long half‑life drugs like fluoxetine (Prozac).
- Some report comparatively easy discontinuation with minimal or no brain zaps; variability is emphasized.
- Several warn that abrupt cessation can trigger extreme mood swings, suicidality, or intense physical symptoms.
Critiques of psychiatry and pharma
- Posters highlight earlier professional dismissal of brain zaps and discontinuation effects, seeing it as tied to marketing SSRIs as “non‑addictive.”
- Some argue psychiatric drugs do far more harm than good and call for drastic reduction or even future legal reckoning.
- Others strongly counter that, despite flaws and overprescribing, SSRIs are among few effective tools for serious depression/anxiety.
Alternatives and adjuncts
- Mentioned options: bupropion (with both highly positive and severely adverse experiences), TMS, ketamine, SAM‑e, psychotherapy/CBT, exercise, light, sleep hygiene, social connection, psychedelics, and acupuncture.
- General caution: do not stop or change psychiatric meds without a careful, medically supervised plan.